Abstract #0030
Confounder-Corrected T1 mapping in the Liver through Simultaneous Estimation of T1, PDFF, R2* and B1
Nathan Tibbitts Roberts1,2, Daiki Tamada, PhD1, Yavuz Muslu1,3, Diego Hernando, PhD1,3,4,5, and Scott B Reeder, MD, PhD1,3,4,6,7
1Radiology, University of Wisconsin - Madison, Madison, WI, United States, 2Electrical Engineering, University of Wisconsin - Madison, Madison, WI, United States, 3Medical Physics, University of Wisconsin - Madison, Madison, WI, United States, 4Biomedical Engineering, University of Wisconsin - Madison, Madison, WI, United States, 5Electrical and Computer Engineering, University of Wisconsin - Madison, Madison, WI, United States, 6Medicine, University of Wisconsin - Madison, Madison, WI, United States, 7Emergency Medicine, University of Wisconsin - Madison, Madison, WI, United States
Synopsis
T1 is emerging as a quantitative MR biomarker of liver fibrosis, the most important histological change predictive of progressing chronic liver disease. 3D spoiled gradient echo (SGRE)-based T1 mapping is preferable in the abdomen for its short acquisition time, volumetric coverage, and robustness to motion. However, SGRE-based T1 mapping is confounded by tissue fat and B1 inhomogeneity. In this work we present a novel SGRE-based T1 mapping method that corrects for both fat and B1 inhomogeneity. Phantom experiments show excellent agreement with reference T1 values (slope=1.01, R2=1.00) and minimal bias (~5±23ms). Early results from 5 healthy volunteers are promising.
This abstract and the presentation materials are available to members only;
a login is required.
Join Here
